CAS 952654-62-5
:(3R,4R,5R,6R)-6-[4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]ethyl]-6-oxo-pyrimidin-5-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
Description:
The chemical substance with the name "(3R,4R,5R,6R)-6-[4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]ethyl]-6-oxo-pyrimidin-5-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid" and CAS number "952654-62-5" is a complex organic compound characterized by its multi-functional groups and stereochemistry. It features a tetrahydropyran ring with multiple hydroxyl groups, indicating potential for hydrogen bonding and solubility in polar solvents. The presence of a pyrimidine moiety suggests biological activity, possibly as an inhibitor or modulator in biochemical pathways. The fluorophenyl and oxadiazole substituents may enhance its pharmacological properties, such as selectivity and potency. The compound's stereochemistry, denoted by the (3R,4R,5R,6R) configuration, implies specific spatial arrangements that can significantly influence its interaction with biological targets. Overall, this substance may have applications in medicinal chemistry, particularly in the development of therapeutics targeting specific diseases or conditions. Further studies would be necessary to elucidate its full biological profile and potential uses.
Formula:C26H29FN6O11
InChI:InChI=1/C26H29FN6O11/c1-10-31-32-21(42-10)20(38)30-26(2,3)25-29-13(19(37)28-9-11-5-7-12(27)8-6-11)17(22(39)33(25)4)43-24-16(36)14(34)15(35)18(44-24)23(40)41/h5-8,14-16,18,24,34-36H,9H2,1-4H3,(H,28,37)(H,30,38)(H,40,41)/t14-,15-,16-,18?,24+/m1/s1
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Raltegravir Glucuronide
CAS:Formula:C26H29FN6O11Color and Shape:White To Off-White SolidMolecular weight:620.55Raltegravir β-D-Glucuronide
CAS:<p>Applications A metabolite of Raltegravir.<br>References Bosma, P., et al.: J. Biol. Chem., 269, 17960 (1994), Richman, D., et al.: Nature, 410, 995 (2001), Williams, J., et al.: Drug Metab. Dispos., 32, 1201 (2004), Miners, J., et al.: Biochem. Pharmacol., 71, 1531 (2006),<br></p>Formula:C26H29FN6O11Color and Shape:NeatMolecular weight:620.54Raltegravir-d3 b-D-Glucuronide (>90%)
CAS:Controlled Product<p>Applications A labelled metabolite of Raltegravir.<br>References Bosma, P., et al.: J. Biol. Chem., 269, 17960 (1994) , Richman, D., et al.: Nature, 410, 995 (2001), Williams, J., et al.: Drug Metab. Dispos., 32, 1201 (2004), Miners, J., et al.: Biochem. Pharmacol., 71, 1531 (2006),<br></p>Formula:C26H26D3FN6O11Purity:>90%Color and Shape:NeatMolecular weight:623.56Raltegravir b-D-glucuronide
CAS:<p>Raltegravir b-D-glucuronide is a synthetic, fluorinated analog of raltegravir. It is a potent HIV-1 integrase inhibitor that has been shown to be active against the majority of HIV-1 strains. Raltegravir b-D-glucuronide is less potent than the parent compound and exhibits reduced antiviral activity in vitro. Raltegravir b-D-glucuronide is metabolized to raltegravir and eliminated in urine as the glucuronide conjugate.</p>Formula:C26H29FN6O11Purity:Min. 95%Color and Shape:White PowderMolecular weight:620.54 g/mol




